; second, several NCI-Frederick Cancer Research and Development FAD-linked mutations in APP alter the processing of Frederick, Maryland 21702 APP in cultured cells, leading to increased levels of A␤1-42 in culture medium (either with or without increasing the levels of A␤1-40) (Cai et al., 1993; Citron et al., Summary 1992; Suzuki et al., 1994) ; third, A␤1-42 is the principal component of amyloid deposits (Roher et al., 1993) ; and Mutations in the presenilin 1 (PS1) and presenilin 2 fourth, immunocytochemical and biochemical studies genes cosegregate with the majority of early-onset that document early and selective deposition of A␤1-familial Alzheimer's disease (FAD) pedigrees. We now 42(43) species in brains of patients with AD (Iwatsubo document that the A␤1-42(43)/A␤1-40 ratio in the con Gravina et al., 1995) and Down's Syndrome ditioned media of independent N2a cell lines express- (Iwatsubo et al., 1995; Lemere et al., 1996a) . More reing three FAD-linked PS1 variants is uniformly elevated cently, massive A␤42(43) deposits were demonstrated relative to cells expressing similar levels of wild-type in the cerebral cortex and cerebellum of individuals with PS1. Similarly, the A␤1-42(43)/A␤1-40 ratio is elevated a PS1-linked E280A mutation (Lemere et al., 1996b) . in the brains of young transgenic animals coexpressTo examine directly the effects of wild-type and muing a chimeric amyloid precursor protein (APP) and tant PS1 on the ratio of A␤ peptide species, we quantian FAD-linked PS1 variant compared with brains of fied the levels of secreted A␤1-42(43) and A␤1-40 in the transgenic mice expressing APP alone or transgenic conditioned medium of stable mouse neuroblastoma mice coexpressing wild-type human PS1 and APP.
(N2a) cell lines that constitutively express human APP These studies provide compelling support for the view in combination with wild-type PS1 or FAD-linked PS1 that one mechanism by which these mutant PS1 cause variants. We document that the ratios of A␤1-42(43)/ AD is by increasing the extracellular concentration of A␤1-40 in media of independent cell lines expressing A␤ peptides terminating at 42(43), species that foster different FAD-linked PS1 variants (i.e., A246E, M146L, or ⌬E9 variants) are uniformly elevated compared with A␤ deposition.
the A␤1-42(43)/A␤1-40 ratios in media from cells that express essentially indistinguishable levels of wild-type PS1. We extended these analyses to examine whether mutant PS1 influences A␤1-42(43) production in the 1A, lanes 10-14), ␣PS1Loop detected variable levels of an ‫04ف‬ kDa PS1 E9 polypeptide, a variant that is not a CNS. We mated transgenic mice expressing either human PS1 (Hu PS1) or Hu PS1 harboring an FAD-linked substrate for endoproteolysis (Thinakaran et al., 1996) , and low levels of the ‫61ف‬ kDa mouse PS1 derivative. A246E mutation with transgenic mice expressing elevated levels of chimeric murine (Mo/Hu) APP-695 harInterestingly, the ‫61ف‬ kDa endogenous mouse PS1 derivative failed to accumulate in cell lines expressing high boring a Hu A␤ domain and mutations (K595N, M596L) linked to Swedish FAD pedigrees (APPswe) (Mullan et levels of the M146L (line ML.10, Figure 1 , lane 7), A246E (line AE.29, lane 9), or ⌬E9 (line ⌬E9.18, lane 14) variants. al., 1992). We document that in the brains of young transgenic animals coexpressing APPswe and mutant These results parallel our earlier demonstration that the mouse ‫61ف‬ kDa PS1 derivative is undetectable in the PS1, the ratio of A␤1-42(43) to A␤1-40 is elevated as compared with transgenic mice expressing APPswe brains of transgenic mice that overexpress human PS1 (Thinakaran et al., 1996) , and appears to be replaced by alone or transgenic mice coexpressing Hu PS1 and APPswe. Collectively, our studies of transfected cells and the human ‫71ف‬ kDa PS1 derivative. In parallel, we examined the levels of N-terminal PS1, transgenic mice provide compelling support for the view that mutant presenilin acquires property(ies) that influ-‫82-72ف‬ kDa derivatives in the N2a lines using Ab14, a polyclonal serum specific for amino acids 3-15 of human ence APP processing in a manner that results in elevated extracellular concentrations of A␤1-42(43), a highly amand mouse PS1 ( Figure 1B ). As expected, Ab14 detected an ‫82ف‬ kDa N-terminal PS1 derivative in N2a cells exyloidogenic peptide that is selectively deposited in the brains of individuals with AD and Down's Syndrome pressing human APP alone ( Figure 1B , lane 1) and ‫34ف‬ kDa and ‫72ف‬ kDa polypeptides, corresponding to full- (Iwatsubo et al., 1994; Gravina et al., 1995; Lemere et al., 1996a) .
length human PS1 and an N-terminal human PS1 derivative, respectively, in N2a lines stably expressing human wild-type PS1 ( Figure 1B , lanes 2 and 3), M146L PS1 Results variant ( Figure 1B , lanes 4-7), or A246E PS1 variant ( Figure 1B , lanes 8 and 9, respectively). As expected,
Expression of Human PS1 and APP in N2a
Ab14 detected the ‫04ف‬ kDa PS1⌬E9 polypeptide in lines Cell Lines expressing the ⌬E9 PS1 variant and the endogenous Stable mouse neuroblastoma (N2a) cell lines were gen-‫82ف‬ kDa N-terminal derivative ( Figure 1B , lanes 10-14). erated that express the following: wild-type human APP In addition, the ‫82ف‬ kDa mouse N-terminal PS1 derivaalone (one line); human APP-695 with human wild-type tive failed to accumulate in cell lines expressing high PS1 (two lines); and human APP-695 with three different levels of the M146L (Figure 1 APP in stable N2a lines, we used antibody CT15, a polyTo examine PS1 expression, we used ␣PS1Loop, an clonal antiserum raised against the C-terminal 15 resiantiserum that specifically reacts with epitopes in the dues of APP (Sisodia et al., 1993) . As expected, CT15 hydrophilic "loop" domain of PS1 (amino acids 263-407) reacted with low levels of mouse APP in untransfected (Thinakaran et al., 1996) . We recently reported that PS1 N2a cells (Figure 2 , lane 1) and high, but variable levels of is subject to endoproteolytic processing in vivo, and the full-length ‫001ف‬ and 105 kDa polypeptides representing preponderant PS1-related species that normally accusynthetic and mature forms of human APP-695, respecmulate in cultured mammalian cells, and in the brains tively, in each of the cell lines (Figure 2 ). [ 35 S]-methionine of rodents, primates, and humans are ‫82-72ف‬ kDa pulse-labelling, immunoprecipitation, and phosphorim-N-terminal and ‫71-61ف‬ kDa C-terminal derivatives (Thiaging analysis revealed that relative biosynthetic rates nakaran et al., 1996) . In untransfected N2a cells (data of human APP in each of the lines were indistinguishable not shown) and N2a cells expressing human APP alone from the steady-state analysis shown in Figure 2 (data ( Figure 1A , lane 1), ␣PS1Loop antiserum detected an not shown). ‫61ف‬ kDa C-terminal PS1 derivative of mouse PS1. Moreover, and consistent with our earlier observations in African monkey kidney COS-1 and human embryonic A␤ in Conditioned Medium of Cell Lines The levels of A␤1-40 and A␤1-42(43) species that accukidney 293 cells expressing human PS1 (Thinakaran et al., 1996) , ␣PS1Loop antiserum detected ‫34ف‬ kDa and mulated in the conditioned medium of N2a cells coexpressing human APP and human PS1 were quantified ‫71ف‬ kDa polypeptides, corresponding to full-length human PS1 and a C-terminal human PS1 derivative, reusing a well characterized BAN-50/BA-27 and BAN-50/ BC-05 sandwich ELISA assay that specifically detects spectively, in N2a lines that stably coexpress human APP and human wild-type PS1 ( Figure 1A , lanes 2 and A␤1-40 and A␤1-42(43), respectively Gravina et al., 1995; Scheuner et al., 1996) . In view of 3). Both the full-length PS1 and ‫71ف‬ kDa human PS1 derivative were detected in lines that stably coexpress the differing steady-state levels of human APP and human PS1 (or PS1 variants) and clonal variability in A␤ the M146L ( Figure 1A , lanes 4-7) or A246E ( Figure 1A , lanes 8 and 9) PS1 variants. These results demonstrate secretion, we chose to calculate the ratio of A␤1-42(43) to A␤1-40 (i.e., the A␤42/40 ratio), instead of comparing that these FAD-linked PS1 variants are efficiently processed. In lines expressing the ⌬E9 PS1 variant (Figure the absolute levels of A␤ for each sample (Table 1 ). The Mouse N2a neuroblastoma cells were cotransfected with expression plasmids encoding wildtype human APP-695 and wild-type human PS1, PS1M146L, PS1A246E, or PS1⌬E9. Detergent lysates (25 g) were fractionated by SDS--polyacrylamide gel electrophoresis (PAGE) and expression of PS1 was analyzed by immunoblotting with PS1Loop antiserum (A) and N-terminal Ab14 antiserum (B). Note that ␣PS1Loop antiserum detects mouse PS1 at about 40% efficiency of human PS1 (Thinakaran et al., 1996) . The positions of full-length PS1 (FL), C-terminal and N-terminal PS1-derived fragments (CTF and NTF, respectively) are marked.
statistical significance was calculated using the nonpar-(0.154 Ϯ .011 versus 0.098 Ϯ .004, P ϭ 0.0102). Significantly, the A␤42/40 ratios were higher in seven lines ametric Mann-Whitney test. The A␤42/40 ratio in medium of N2a lines expressing human APP alone, or in that expressed mutant PS1 (i.e., ML.2, ML.11, ML.4, AE.23, AE.29, ⌬E9.23, and ⌬E9.21) at levels lower than, combination with wild-type human PS1, were comparable (0.093 Ϯ 0.004 and 0.100 Ϯ 0.006, respectively). In or equivalent to, wild-type human PS1 in lines wt.3 and wt.25 (0.128 Ϯ 0.004 versus 0.1 Ϯ 0.006, respectively; this regard, despite an ‫-3ف‬fold difference in the level of human PS1 expression between lines wt.3 and wt.25 P ϭ .0405). Interestingly, and for reasons not presently clear, an ‫-2ف‬fold increase in expression of PS1⌬E9 in (Figures 1A and 1B, lanes 2 and 3), the A␤42/40 ratio in these lines were quite comparable (0.094 Ϯ 0.006 and line ⌬E9.9 compared with line ⌬E9.21 ( Figure 1A , lanes 10 and 11) resulted in a remarkable increase in the A␤42/ 0.106 Ϯ 0.011, respectively). However, stable lines expressing the M146L ( Figures 1A and 1B Detergent lysates (25 g) prepared from untransfected N2a cells (N2a) and stable N2a lines coexpressing human wild-type APP and human PS1 polypeptides (wild-type PS1, PS1M146L, A246E, or PS1⌬E9) were fractionated by SDS-PAGE, and APP expression was examined by immunoblotting with CT15 antiserum.
created by replacing sequences encoding the A␤ do- (Thinakaran et al., 1996) . The levels of human A␤ were determined using a quantitative sandwich ELISA assay, described above Gravina et late to equivalent levels (Thinakaran et al., 1996) . We from the mutant PS1 polypeptide (data not shown).
All mutant lines average 0.154 Ϯ 0.011; P ϭ 0.0102.
Thus, the A246E mutation does not conspicuously alter a P values were calculated by nonparametric Mann-Whitney test.
proteolytic processing of the PS1 variant in brain, consistent with our findings in stably transfected N2a cells (see above).
In the brains of mice from wild-type PS1 mice (line a line expressing the highest levels of the M146L variant S8-4), we observed high levels of accumulated full-(ML.10; Figure 1 , lane 7) was 0.200 Ϯ 0.001. In this length 43 kDa species. In earlier studies, we demoninstance, high levels of full-length M146L PS1 also accustrated that human PS1 mRNA is highly overexpressed mulated.
in the brains of line S8-4, and we argued that accumulaAt present, the relative contributions of full-length mution of full-length human PS1 is the result of high syntant PS1 or its fragments to A␤42/40 production is unsetthetic rates of transgene-encoded mRNAs (Thinakaran tled. We reported that the preponderant PS1 species in et al. , 1996) . In those studies, we also documented that vivo are its endoproteolytic derivatives (Thinakaran et the levels of accumulated N-terminal human PS1 fragal., 1996); in stably transfected cells, it is conceivable ments in brains of line S8-4 were indistinguishable from that accumulated full-length mutant PS1 may elevate the levels of accumulated N-terminal fragments in brains the A␤42/40 ratios in a manner that is nonphysiologic.
of independent lines of mice expressing human PS1 However, it is quite clear that in lines expressing different mRNA at levels ‫-01ف‬ to 20-fold lower than mRNA in line mutant PS1 with nearly undetectable levels of accumu-S8-4 (Thinakaran et al., 1996) . From these analyses, we lated full-length mutant PS1 (lines ML.2, AE.23, and concluded that accumulation of the PS1 endoproteolytic ⌬E9.23), the A␤42/40 ratio averaged 0.133 compared derivatives is highly regulated and saturable. In contrast with wild-type PS1-expressing lines that exhibited an to line S8-4, very little full-length A246E PS1 accumu-A␤42/40 ratio of 0.1, despite the accumulation of fulllated in the brains of line N5, consistent with Northern length wild-type PS1.
blot analyses, which demonstrated that brain mRNA levels in line N-5 are ‫-3ف‬ to 5-fold lower than in line Expression of Human PS1 and Human APP S8-4 (data not shown). Interestingly, the levels of accuin Transgenic Mice mulated N-terminal human PS1 fragments in brains of To examine the influence of mutant PS1 on A␤42/40 lines N5 and S8-4 are quite comparable, despite the ratios in an in vivo setting, we examined A␤42/40 ratios accumulation of full-length wild-type PS1 in line S8-4. in the brains of transgenic mice expressing wild-type or Total APP levels in detergent extracts from the brains mutant PS1. Mice expressing either wild-type Hu PS1 of the APPswe transgenic mice and mice coexpressing or the FAD-linked A246E PS1 variant were mated to APPswe and Hu PS1 were examined by immunoblotting transgenic mice expressing a chimeric Mo/Hu APPwith CT15, an APP C-terminal specific antiserum; the CT-15 epitope is conserved in human and murine APP. 695swe (APPswe) polypeptide. The APPswe cDNA was Total SDS extracts of brain protein were analyzed by immunoblotting with CT15, an antibody that recognizes both murine and human APP. Mice harboring the APPswe transgene show an ‫2ف‬ fold increase in APP immunoreactivity. Lanes 1 and 2, nontransgenic mice; lanes 3 and 4, transgenic mice harboring APPswe transgenes alone; lanes 5 and 6, transgenic mice harboring APPswe and mutant human PS1 transgenes; lanes 7 and 8, transgenic mice harboring APPswe and wild-type human PS1 transgenes. sandwich ELISA assays, described above Gravina et al., 1995; Scheuner et al., 1996) . Although the absolute levels of A␤1-40 and A␤1-42(43) in the brains of transgenic mice varied considerably, coexpression of mutant PS1 with APPswe disproportionately elevated the concentration of A␤1-42(43) relative to A␤1-40 ( Figure 5) ; the A␤42/40 ratio shifted from a mean of 0.215 (SE ϭ 0.011) in littermate mice expressing APPswe alone (Group A) to a mean of .305 (SE ϭ 0.014) in mice expressing both APPswe and mutant PS1. Im- between the two groups was highly significant (P ϭ parametric Mann-Whitney analyses revealed that the 50% increase in the A␤42/40 ratio in the brains of mice expressing both APPswe and mutant Hu PS1 as compared with mice expressing APPswe alone (Groups A We observed an increase in the levels of accumulated 100-110 kDa APP (Figure 4 , lanes 3-8) compared with and B) was highly significant (P ϭ 0.001). Thus, despite the variability in total A␤ levels, the effects of mutant littermates lacking transgenes (Figure 4, lanes 1 and 2) . Phosphorimaging analysis of CT-15 immunoblots indiHu PS1 were sufficiently robust to cause detectable, and highly statistically significant, increases in the A␤42/ cated an ‫-2ف‬fold increase in APP levels in mice harboring the APPswe transgene. Parallel analyses with mAb 40 ratio.
To examine the effects of human wild-type PS1 on 6E10, specific for human A␤ sequences (Kim et al., 1988 (Kim et al., , 1990 Hsiao et al., 1995) , confirmed the presence of A␤42/40 ratios, we examined the brains of two mice coexpressing APPswe and wild-type human PS1. We humanized A␤ domains in the APPswe polypeptides (data not shown).
observed that the A␤42/40 ratio in these animals was 0.192, a value not statistically different from the mice expressing APPswe alone ( Figure 5 ). Thus, increasing A␤ Levels in Brains of Transgenic Mice Coexpressing Human PS1 and Human APP PS1 expression alone is not sufficient to alter the A␤42/ 40 ratio. Moreover, a significant shift in the A␤42/40 ratio Levels of A␤ were measured in homogenates of brains from 2-to 3-month-old transgenic mice by quantitative (P ϭ 0.05) was observed when we compared values for FAD-linked mutations cause AD by increasing the extracellular concentration of highly amyloidogenic A␤1-42(43) species, thus fostering A␤ amyloid deposition in the brain.
To examine directly the influences of wild-type and mutant PS1 on A␤1-40 and A␤1-42(43) production, we generated stable mouse neuroblastoma (N2a) cell lines that constitutively express human APP in combination with human PS1 or FAD-linked PS1 variants. We extended these investigations to analyze the A␤1-42(43) to A␤1-40 ratio in the CNS of transgenic mice that express a chimeric APP (APPswe) in combination with wild-type PS1 or the FAD-linked A246E PS1 variant.
Our findings provide the first demonstration of a bona fide effect of wild-type and mutant PS1 on A␤42(43) production in vitro and in vivo and offer important insights into the pathogenetic mechanism of PS1-linked FAD. First, we document that the ratio of A␤1-42(43)/ A␤1-40 in the medium of independent cell lines expressing variable levels of either the A246E, the M146L, or ⌬E9 PS1 variants is uniformly elevated compared with medium of cells expressing wild-type PS1. In these studies, elevated extracellular A␤42(43) accumulation, mediated by mutant PS1, occurred in independent lines that express the M146L, A246E, or ⌬E9 variants at levels lower than, or comparable with, lines expressing human wild-type PS1. Second, we document that the ratio of A␤1-42(43) to A␤1-40 in the brains of young transgenic animals coexpressing APPswe and mutant PS1 is elevated by 50% compared with transgenic mice expressing APPswe alone or transgenic mice coexpressing unpublished data). Hence, the alterations in A␤1-42(43)/ A␤1-40 ratios detected in the brains of our young animals coexpressing APPswe and mutant PS1 are not the mice coexpressing wild-type PS1 and APPswe (0.192) consequence of pathogenic processes, but rather are and mice coexpressing mutant PS1 and APPswe (0.305).
indicative of fundamental changes in the processing of The higher level of transgene expression in wild-type APP. Collectively, the data obtained from stably trans-PS1 mice (line S8-4) underscores the significance of fected cells and brains of transgenic mice provide comthese observations and leads us to conclude that only pelling support for the view that one mechanism by mutant Hu PS1 influences APP processing in a manner which mutant PS1 causes AD is the acquisition (or enthat enhances A␤1-42(43) production. hancement) of property(ies) that influence APP processing in a manner that leads to increased extracellular Discussion concentrations of A␤1-42(43). Our findings are notable in view of several lines of Mutations in PS1 and PS2 cosegregate with the majority evidence in support of the idea that A␤1-42(43) plays a of pedigrees with early-onset FAD, but the molecular critical role in the pathogenesis of AD: first, biophysical mechanism(s) by which FAD-linked PS1 and PS2 varistudies demonstrate that A␤1-42 has rapid nucleation ants cause AD are unclear. The absence of nonsense and aggregation kinetics (Jarrett and Lansbury, 1993); or frameshift mutations leading to truncated PS1/PS2 second, mass spectrometric analyses of purified amysupport the notion that AD is caused not by the loss, loid plaques revealed that A␤1-42 is the principal combut by the gain, of deleterious properties of the mutant ponent of amyloid deposits (Roher et al., 1993) ; third, polypeptides. In this regard, recent studies indicate that cells expressing FAD-linked APP with missense mutaconditioned medium from fibroblasts or plasma of aftions at position 717 (of APP-770) secrete high levels of fected members of pedigrees with PS1/PS2-linked mu-A␤1-42(43) ; and fourth, biochemical tations show a significant increase in the ratio of A␤1-and immunocytochemical studies of brains from pa-42(43)/A␤1-40 relative to unaffected family members tients with AD (Iwatsubo et al., 1994; Gravina et al., 1995) and Down's Syndrome (Iwatsubo et al., 1995; Lemere (Scheuner et al., 1996) . These data suggest that the and bound radioactivity was quantified by phosphorimaging (Molecet al., 1996a ) using end-specific antibodies revealed that ular Dynamics, Sunnyvale, CA).
A␤ species terminating at residue 42(43) occur early and selectively in both diffuse and compact amyloid with a PS1-linked E280A mutation with amyloid burdens vector, pCB6 (Lo et al., 1994) . Expression of human PS1 in G418-that far exceeds that described for individuals homozyresistant lines was determined by Western blot analysis with polygous for apoE4 alleles (Roses, 1994; Hyman et al., 1995) .
clonal ␣PS1Loop and Ab14 antisera (Thinakaran et al., 1996) . ExAll of these lines of evidence indicate that A␤1-42 (43) pression of human APP was determined by Western blot analysis is a critical peptide in the pathogenesis of amyloid depowith CT15 antiserum. One N2a line expressing APP and undetectable levels of human PS1 (wt.7), two wild-type PS1 lines (wt.3 and sition. These converging lines of evidence, in conjuncwt.25), four PS1M146L lines (ML.2, ML.4, ML.10, and ML.11), two tion with our demonstration that mutant PS1 influences Transgenic mice expressing wild-type Hu PS1 were previously described (Thinakaran et al., 1996) . In the present study, we used a line of transgenic mice expressing very high levels of wild-type Hu Experimental Procedures PS1 (line S8-4) (Thinakaran et al., 1996) . To generate transgenic mice expressing the A246E PS1 variant, we injected pronuclei with linealized expression plasmid, MoPrP. A246E, described above. All
Generation of PS1 Expression Vectors
Hu PS1 transgenic mice were maintained as C3H/HeJ ϫ C57BL/6J A cDNA-encoding human PS1 was generated as described (Slunt et hybrids. al., 1995) . PS1 cDNA encoding the A246E substitution was generated
To generate cDNA encoding Mo/Hu APP-695swe, a PCR-based by RT-PCR of cytoplasmic RNA isolated from skin fibroblasts of a strategy was utilized in which the oligonucleotide primers encoded patient harboring the A246Emutation (NIA Cell Repository #AG06848B) the "Swedish" missense mutations and contained appropriate reusing the primer pair, hAD3-ATG-Kpn (GGGGTACCATGACAGAGTT striction endonuclease sites to allow for the construction of chimeric ACCTGCAC) and hAD3-R-3ЈUTR (CCGGGATCCATGGGATTCTAAC APP. The cDNA were sequenced prior to insertion into the MoPrP. CGC). PCR product was digested with Asp-718 and BamHI, and ‫4.1ف‬
Xho vector. Mice harboring the APPswe transgene were initially kB PS1 cDNA was gel purified and ligated to Bluescript KSϩ vector generated in F2 hybrids of C3H/HeJ ϫ C57BL/6J mice. The F3 (Stratagene, La Jolla, CA) previously digested with Asp-718 and BamHI, progeny of these matings were subsequently mated to C57BL/6J to generate phPS1A246E. The cDNA were sequenced in their entirety for one generation (APPswe B6n1) before mating to mice harboring using a Sequenase (U. S. B, Cleveland, OH). To generate human PS1 PS1 transgenes (all of which were F3 progeny of C3H/HeJ ϫ C57BL/ cDNA encoding the M146L substitution, we used a four-way PCR 6J matings). strategy with two primer pairs and full-length PS1 cDNA as template. The primer pairs for the initial PCR reactions were hAD3-M146LF (GTC Analysis of A␤1-40 and A␤1-42(43) Secreted ATTGTTGTCCTGACTATCCTCCTG)/hAD3-R284 (GAGGAGTAAATGA by Stable N2a PS1/APP Lines GAGCTGG) and hAD3-M146LR (CAGGAGGATAGTCAGGACAACAAT Stable N2a lines were plated 1 ϫ 10 6 cells/60 mm dish and main-GAC)/hAD3-237F (CAGGTGGTGGAGCAAGATG). PCR products from tained in 1:1 OptiMEM (GIBCO-BRL, Bethesda, MD) and Dulbecco's each reaction were gel purified, combined, and subject to a second modified Eagle's medium supplemented with 10% fetal bovine seround of PCR with primers hAD3-237F and hAD3-R284. The resulting rum. The following day, culture medium was replaced with fresh product was digested with KasI and PflMI and an ‫003ف‬ bp gelmedium containing 10 mM butyrate (to induce transcription of the purified fragment was ligated to KasI/PflM1-digested phPS1 to gen-CMV promoter-driven human APP cDNA) (Lo et al., 1994) . The condierate phPS1M146L. The inserts and junctions were sequenced using tioned medium was collected 24 hr later and stored frozen at Ϫ70ЊC. Sequenase (U. S. B, Cleveland, OH). The strategy for generating
The samples were coded in order to facilitate a blinded comparison. cDNA encoding PS1 lacking exon 9 (amino acids 290-319) was Aliquots of conditioned medium were analyzed by BAN-50/BA-27 described previously (Thinakaran et al., 1996) . Sequences encoding or BAN-50/BC-05 sandwich ELISA assays essentially as previously PS1 variants were subcloned downstream of mouse prion promoter described Scheuner et al., 1996) to measure in plasmid MoPrP. Xho (Thinakaran et al., 1996) , to generate MoPrP.
A␤1-40 and A␤1-42(43), respectively. PS1 expression plasmids.
Analysis of A␤1-40 and A␤1-42(43) in Brain Tissue Antibodies
Approximately 150 mg of tissue was dounce homogenized (6 Two antibodies directed against N-terminal epitopes of PS1 were strokes) in 1 ml of 70% formic acid. Homogenates were centrifuged used in this study: Ab14 is a polyclonal serum specific for amino at 100,000 ϫ g for 1 hr to remove particulate material. The supernaacids 3-15 of human and mouse PS1 (Thinakaran et al., 1996) , and tant was recovered and neutralized with a 20-fold dilution in 1 M mAb N-term is a concentrated cell culture supernatant from a rat Tris base. Following neutralization, 100 l of the sample was mixed myeloma primed with a chimeric protein consisting of the N-terminal with 50 l of EC buffer (0.02 M sodium phosphate, 0.2 mM EDTA, 80 amino acids of human PS1 fused to bacterial glutathione 0.4 M NaCl, 0.2% BSA, 0.05% CHAPS, 0.4% Block-Ace, 0.05% S-transferase. ␣PS1Loop, an antiserum that specifically reacts with sodium azide [pH 7.0]) and analyzed directly using the BAN-50/ epitopes in the hydrophilic loop domain of PS1 (amino acids 263-BA27 and BAN-50/BC05 sandwich ELISA system 407) (Thinakaran et al., 1996) was used to detect PS1 C-terminal Gravina et al., 1995; Hsiao et al., 1995; Scheuner et al., 1996) . The derivatives.
values obtained were calculated by comparison with the absorbanFor Western blot analysis, detergent lysates were prepared from ces obtained from a standard curve of synthetic A␤1-40 and A␤1-42 cells and transgenic mouse brains as described previously (Thina-(Bachem, King of Prussia, PA), adjusted for sample dilution, and karan et al., 1996) . The steady-state expression of PS1 and APP in converted to pmols/g wet weight tissue. cultured cells and mouse brain was examined by Western blot analysis using PS1-specific, ␣PS1Loop, and Ab14 antisera, and APPAcknowledgments specific CT15 antisera (Sisodia et al., 1993 
